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Foreword 
 
In 2012 the Steering Group of the HSE Pharmacy Needle Exchange Programme, was requested by the HSE 
National Office for Social Inclusion to undertake an effectiveness review of all forms of needle exchange (NEX).  
 
NEX, which falls under the auspices of the steering group for the Pharmacy Needle Exchange in compliance with 
the Key Results Area in the HSE's National Service Plan 2012, balances the need for information about needle 
exchanges across the country provided by statutory and non-statutory services with the need to keep 
information concise and uniform across reporting formats. 
 
It also builds on the information provided in Needle Exchange Provision in Ireland: The Context, Current Levels 
of Service Provision and Recommendations, a joint report published in November 2008 by the National Drugs 
Strategy Team and the National Advisory Committee on Drugs.  
 
The report is in line with the current National Drugs Strategy (2009 – 2016), specifically Action 34 relating to 
expansion of the availability of, and access to, needle exchange services where required. It provides a timely 
assessment of needle exchange services in the context of the external evaluation of the PNEX programme, 
assesses the enhanced provision of needle exchange services and how the various forms of needle exchange 
integrate/dovetail with one other. 
 
This report on Needle Exchange Provision in Ireland is aimed at improving needle exchange coverage and 
enhancing service delivery as a way of reducing rates of new HCV and HIV infection and charts a way forward in 
identifying potential care pathways for drug and alcohol services in this country. 
 
 
Joe Doyle 
HSE National Planning Specialist: Social Inclusion  
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Executive summary 
 
Recommendations 
1. Service user feedback 
 
A service user satisfaction survey of all the different NEX services should be carried out in line with Goal 
6 of the HSE National Strategy for Service User Involvement in the Irish Health Service 2008-2013.  
 
2. Data collection 
 
a) A standardised electronic reporting mechanism for regular monitoring and reporting of all needle 
exchange transactions should be considered; preferably as part of the HSE Primary Care ICT system. NEX 
service information should ideally be reported to a central office on a quarterly basis. 
 
b) Unique identifier 
 
A unique identifier for each service user should be developed to remove the risk of an individual being 
counted more than once in a reporting year. The unique identifiers need to comply with the obligations 
of the Data Protection Act 1988, the Data Protection (Amendment) Act 2003 and SI535 of 2003 (as 
amended). The HSE has proposed to use a health service identification number for the each individual in 
the state for use in health or social care services and if possible the unique identifier should be linked to 
a health identifier, while preserving the anonymous nature of the service. 
 
c) Image and Performance Enhancing Drugs (IPEDs) 
 
NEX services should collect data from those who are using image performance and enhancing type drugs 
as this has been highlighted as an emerging trend. 
 
 
 
3. NEX Service Training and Policies 
 
a) All NEX service providers should  ensure  training complies with recognised standards, such as the 
Quality in Alcohol and Drug Services (QuADS) Organisational Standards (ALDP, HSE 2014); the 
Hepatitis C Strategy 2011, Recommendation 20; and Building a Culture of Patient Safety 2008- 
Report of the Commission on Patient Safety and Quality Assurance. 
 
b) NEX service providers must ensure policies and procedures are in place to comply with QuADS 
Organisational Standards (ALDP, HSE 2014). 
 
c) NEX service providers must also operate an effective clinical governance framework in line with 
QuADS Organisational Standards (ALDP, HSE 2014) or an equivalent professional body. 
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4. Blood Borne Virus (BBV) testing and Hepatitis B vaccination 
 
NEX service providers should examine potential barriers to BBV testing and immunisation in order to 
improve testing and immunisation uptake. 
 
5. Equipment and supply considerations 
 
a) Equipment supplied should be of high quality and meet European safety standards where available. 
Consideration should be given to including stericups, filters and foil in every NEX service (this is not 
currently the case). 
b) Stock provision for all non-pharmacy NEX services should be centrally purchased and distributed to 
ensure value for money, quality and consistency of equipment.  
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Background 
 
Needle Exchange Programmes are intended to: 
 
1. Prevent the spread of HIV and Hepatitis C through reducing their transmission by providing sterile 
injecting equipment 
2. Prevent the development of localised bacterial infections, such as abscesses, by providing sterile 
injecting equipment  
3. Prevent overdose through information on how to recognise it and what to do should it occur  
4. Prevent the move from smoking to injecting and lower the incidence of injecting through the provision 
of tinfoil 
5. Facilitate sterile and safe injecting through the provision of equipment, information and safer injecting 
training 
6. Provide information on the importance and availability of HIV and Hepatitis C testing  
7. Manage localised bacterial infections through referral for the provision of sterile dressing and 
medication (where necessary)  
8. Provide information to the drug user in respect of relevant social and addiction services and refer the 
drug user to same when appropriate 
 
 
 
NEX services should provide sterile injecting equipment and facilitate the return of used equipment in order to 
prevent the spread of BBVs. They should also supply condoms as applicable. NEX services may also refer an 
individual to other relevant services such as:  
 Drug treatment 
 BBV/testing 
 Hepatitis B vaccination 
 Homeless services 
 
Where appropriate, some services may also have qualified outreach drug workers on site who can offer advice 
and provide specialist injecting equipment.   
 
International evidence demonstrates that a mix of needle exchange models should be in place to maximise 
service user access to such services, (Cox & Robinson, 2008). There are advantages and limitations to the three 
most common models of exchange, i.e. fixed location; mobile/outreach; and pharmacy based.  
 
1. Fixed location 
 
Fixed-site exchanges allow services to provide education about harm minimisation strategies and to 
facilitate the distribution and disposal of drug-taking paraphernalia. However, they may have limited 
opening hours and be characterised by a lack of accessibility and privacy. Outreach provisions help to 
ameliorate such limitations by increasing accessibility, convenience and anonymity for service users. 
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2. Mobile/Outreach backpacking 
 
Outreach services can distribute sterile drug-taking paraphernalia and facilitate the return of used 
equipment as well as providing education about harm-minimisation. Typically, specially-trained staff 
(outreach workers) access service users via a purpose-built minibus or at a pre-appointed location, for 
example a service user’s home. Such services have been shown to be the most ‘economical’ form of needle 
exchange provision, (Cox and Robinson, 2008), and offer a high degree of discretion for the service user. This 
type of service is useful where injecting drug use is hidden, or rare, or is a widely dispersed phenomenon. 
However, concerns continue over staff safety - particularly during backpacking. 
3. Pharmacy –based needle exchanges 
 
The advantages of pharmacy-based needle exchanges are longer opening hours, greater service user 
convenience (pharmacies are usually situated in local residential areas) and the ability to serve small 
numbers of individuals in a specific place. Their relative ease of access also tends to facilitate contact 
between service users and healthcare professionals. Pharmacy-based needle exchanges can be a portal for 
referral to addiction services, as well as related health and social services. In the UK, pharmacies distribute a 
greater number of sterile injecting packs than any other type of needle exchanges service.  
 
The structure and operation of needle exchange programmes vary widely depending on historic development, 
local conditions, funding and staffing levels. This has lead to the development of different models of operating 
needle exchange, influenced by economic and geographical factors, including urban/rural variations, all of which 
affect drug user up-take of the services. There are strengths and weaknesses to all three models. However, the 
combination of the three ensures the most user-friendly provision, accessibility to the service and regular 
engagement with the services. Pharmacy-based programmes complement other models as they provide access 
to a somewhat different population of injecting drug users, (Cox & Robinson, 2008; WHO, 2004). 
 
Needle and syringe exchange services were first provided in Ireland in 1989 in the former Eastern Health Board 
AIDS Resource Centre in Baggot Street, Dublin 2, as a response to the emerging opiate misuse problem in the 
capital. Reflecting changing patterns of prevalence since then, the availability of needle exchange has grown 
significantly across the country, with a range of services offering this intervention.  
 
The National Drugs Strategy 2009 – 2016 noted limited availability of NEX services in five of the 10 Regional Drug 
Task Forces and in 13 out of 14 Local Drug Task Forces, (NDS, 2008). Subsequently, the national PNEX service 
was initiated in 2011. It was based on a recommendation of Action 34 of the National Drugs Strategy 2009-2016,  
which highlighted the need to expand the availability of needle exchanges services, where required. The PNEX 
program is a joint initiative between the Elton John AIDS Foundation, the HSE and the Irish Pharmacy Union 
(IPU). Prior to this initiative, the provision of clean equipment for injecting drug users was mainly limited to the 
east of the country and was provided by both statutory and voluntary agencies funded by the HSE.  
 
The PNEX programme covers all areas outside of Co. Dublin, Co. Wicklow and Co. Kildare.  
 
To assess the effectiveness of needle exchange services, PNEX was asked to carry out a review of all fixed site, 
mobile/outreach and pharmacy-based services in 2012. 
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The review was designed to assess: 
 
o The existence of clinical governance and quality assurance policies and procedures 
o Whether data collected regarding service users and needle exchange services met national and 
international standards 
o Needle exchange activity in 2012 
o Referral rates to healthcare and social services 
o Needle exchange provision throughout the country 
 
 
Research questions 
 
The following issues were considered in the review: 
 
1. What is the nature of the service provided by the various types of programme? 
2. How are needle exchanges distributed throughout Ireland? 
3. What types of injecting and other drug-use paraphernalia are distributed?  
4. Are there gaps in service provision and, if so, where are they? 
5. What quality assurance policies and procedures are used on the needle exchange programme? 
6. Does the data collected follow international and national requirements?  Are there data gaps; and, if so, 
where are they? 
7. What are the trends in newly diagnosed cases of HIV and Hepatitis C? 
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Methodology 
 
The review was designed to gather information from those responsible for the planning and delivery of HSE-
funded needle exchange programmes.  Data collection was carried out from February to  June 2013  using the 
questionnaire see appendix 1  
 
It focused on a range of issues. In the case of non-pharmacy based services, it centred on data collection - 
particularly in relation to needle exchange activity (including the number of transactions, number of service 
users, number of syringes, needles and other paraphernalia distributed and returned), as well as quality 
assurance policies and procedures in individual needle exchange services.  
 
As clinical governance and data collection procedures were already in place for pharmacy-based services 
(overseen by the National Liaison Pharmacist HSE Drug Addiction and supported by the Pharmaceutical Society 
of Ireland) the review focused on service delivery for pharmacy-based services. 
 
Numeric and text based data was collected using a data collection template (Appendix 3). The questions were 
agreed by the steering group of the PNEX Programme. The PNEX office liaised with the Health Research Board to 
ensure this template met the overall objectives for the review and to provide assurance that the data requested 
met the data recording requirements of the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). 
 
All members of the HSE National Advisory Addiction Governance Group (NAAGG) were consulted and requested 
to supply details of needle exchange services in their areas. These individual services were then contacted and 
requested to complete the data collection template using data from 2012.  
 
Prior to undertaking this study, there was limited up-to-date data in relation to service users attending needle 
exchange services and on the provision of equipment. As a result of this, the data supplied for this review is 
incomplete in two exchanges. It is acknowledged that this omission may limit the completeness and robustness 
of the results. On the whole, however, the data is representative of needle exchange activity nationally. 
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Findings 
Response rates 
 
All HSE areas completed the questionnaire, including 48% of pharmacies that recorded transactions. Data on all 
transactions and service users is also available from the Pharmacy Needle Exchange, which is submitted 
quarterly in arrears by the pharmacists participating in the programme. 
 
 
Table 1: Sampling frame and response rates for review 
 
 Total number in Ireland Number invited to participate Number responded Response rate 
HSE regions* with needle exchanges 4 4 4 100% 
Voluntary sector needle exchanges in Ireland 6 6 6 100% 
Total pharmacies 
 
*Pharmacies which had transactions  
63 
 
33 
63 
 
16 
16* 
 
16 
25% 
 
48% 
*The HSE regions are;  
1. Dublin Mid-Leinster: Dun Laoghaire, Dublin South East, Dublin South City, Dublin West, Wicklow-Kildare/West-Wicklow, Dublin South West, 
Longford, Laois, Offaly, and Westmeath 
2. Dublin North East: Louth, Meath, Cavan and Monaghan and north of Dublin city and county 
3. HSE South: Cork, Kerry, Waterford, Wexfoxd, Carlow, Kilkenny and South Tipperary 
4. HSE West: Donegal, Sligo, Leitrim, Mayo, Galway, Roscommon , North Tipperary and Limerick  
Since the review was undertaken, reform / restructuring has taken place into Community Health Organisations and these regions do not presently 
exist, further information is available at http://www.hse.ie/eng/services/publications/corporate/CHO_FAQ.pdf   
Models of Needle Exchange in Ireland 
 
There are three models of needle exchange in Ireland:  
 
1. Static - mainly in Dublin City 
2. Outreach - mainly in Counties Dublin, Kildare, Laois, Offaly, Waterford and Wicklow 
3. Pharmacy - in regions outside Dublin, Kildare and Wicklow 
 
In 2012 there were: 
 
 24 static sites 
 14 outreach sites 
 63 pharmacies available to participate, of which 33 had needle exchange transactions.  
 
In 2014, 129 pharmacies were participating in the scheme. 
Geographical distribution of NEX  
 
The study looked at the location of the different types of needle exchange services in Ireland. The details are 
presented below.  
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Table 2: Number, type and location of needle exchange services, 2012 
 
Area Static  Outreach/Mobile  Pharmacy  
HSE Dublin Mid-Leinster 14 6 11 
HSE Dublin North East 4 2 9 
HSE South  4 1 24 
HSE West 2 2 19 
Ireland 24 11 63 
*MQI Dublin counted as 2 (1 outreach and 1 fixed) 
 
The highest number of static needle exchanges is in Dublin Mid-Leinster, which reflects the numbers and 
clustering of injecting drug use in areas of Dublin. The number of reported outreach needle exchange services is 
relatively small and evenly spread throughout the region. Pharmacy-based needle exchange services are based 
outside counties Dublin, Kildare and Wicklow and serve the small clusters of injecting drug users in the towns 
throughout the remainder of Ireland. There are no static or outreach needle exchange services in counties Cork 
or Kerry, with very limited availability of static or outreach needle exchange in counties Louth, Meath, Cavan and 
Monaghan.  
 
Access to static and outreach services varied. One of the static services opened between 9am-6pm Monday to 
Friday, while others had far more limited opening hours. The majority of static services opened between one 
and six hours a week and sometimes only once a week. None of the static or outreach services operated at 
weekends. Pharmacies usually open 48 hours a week or eight hours a day Monday-Saturday inclusive and some 
pharmacies also open on Sundays for limited hours. This indicates a potential 3,408 hours a week of pharmacy-
based needle exchange delivered by 63 pharmacies. However, only 33 out of the 63 pharmacy needle exchanges 
reported any transactions in 2012. 
 
Table 3: Opening hours for static and outreach services, 2012 
 
 Static  Outreach (including mobile and back 
packing)* 
Open 3.5 hours or less a week 11 2 
Open 4 hours to  8 hours a week 4 3 
Open 9 to  24 hours a week 0 2 
Open 25 to 43 hours a week 7 5 
Open whenever needed 0 2 
No hours recorded 2 0 
Total 24* 14* 
*MQI Dublin counted as 2 (1 outreach and 1 fixed 
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Activity  
 
This section describes needle exchange activity in Ireland during 2012. Information includes the numbers of 
service users, transactions (or needle exchange contacts) and syringes distributed. The figures for static and 
outreach services were reported as a combined figure. Three static or outreach services were unable to provide 
data on the number of individuals attending their services. Two static services were unable to provide the 
numbers of needles or syringes distributed. Therefore, the data is an underestimate of needle exchange services 
in the Dublin North East, Dublin Mid-Leinster Region and HSE West. 
Who attends needle exchanges? 
 
The data collated showed that at least 13,763 individuals used needle exchange services during 2012 (Figure 1). 
More than two-thirds (67%) of transactions were at static or outreach services and one-third (33%) at pharmacy-
based needle exchange services (Figure 2). The proportion of individuals attending either static/outreach or 
pharmacy-based models of needle exchange depended on the dominant model of needle exchange in an area.  
 
Of the 13,763 individuals who received needle exchange services, 7,359 (80%) were men and 1,862 (20%)* were 
women. This ratio did not differ by model of needle exchange (Figures 3 and 4) and in general reflected the 
national proportion of four males to one female. The single exception was in HSE South, where the ratio was 
three males to one female (Figure 5).  
 
*Currently there is no unique health identifier system in place in Ireland. This means service users can be 
counted more than once in a reporting year. 
 
 
 
Figure 1: Number of individuals who attended needle exchange services by region and model of service, 2012 
Total 
Dublin North 
East 
Dublin Mid 
Leinster 
South West 
Static and outreach needle exchange 
services 
9221 1790 7212 92 127 
Pharmacy needle exchange services 4542 610 234 2386 1312 
All needle exchange services 13763 2400 7446 2478 1439 
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Figure 2: Proportion of individuals who attended needle exchange services by region and model of service, 
2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Numbers attending needle exchange services by model of service and gender, 2012 
 
 
Total 
Dublin North 
East 
Dublin Mid 
Leinster 
South West 
Pharmacy needle exchange services 33.0 25.4 3.1 96.3 91.2 
Static and outreach needle exchange 
services 
67.0 74.6 96.9 3.7 8.8 
Static and outreach 
needle exchange 
services 
Pharmacy needle 
exchange services 
All needle exchange 
services 
Male 7359 3558 10917 
Female 1862 984 2846 
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Figure 4: Proportion (%) attending needle exchange services by model of service and gender, 2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Proportions attending needle exchange services in each region by gender, 2012 
 
Dublin North East Dublin Mid Leinster South West 
Female 18.5 19.9 24.1 22.3 
Male 81.5 80.1 75.9 77.7 
Static and outreach needle 
exchange services 
Pharmacy needle exchange 
services 
All needle exchange services 
Male 79.8 78.3 79.3 
Female 20.2 21.7 20.7 
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Transactions 
Activities conducted through needle exchanges in 2012 
 
The data presented in Figures 6 and 7 indicate 65,099 transactions took place at needle exchange services during 
2012. The majority (84%) of transactions were at static or outreach services and 16% were at pharmacy-based 
needle exchange services. When HSE regions are compared, the majority of transactions were at static needle 
exchanges in Dublin Northeast followed by Dublin Mid-Leinster. In the south, the vast majority of transactions 
took place at pharmacy-based needle exchange services. In the west, just under half of the transactions took 
place at pharmacy-based needle exchange services and the balance at static or outreach services.  
 
 
 
Figure 6: Number of transactions at needle exchange services by region and model of service, 2012 
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Figure 7: Proportion of transactions at needle exchanges by region and model of service 
 
As mentioned previously two services were unable to provide accurate data on their distribution of needle 
exchange equipment. Pharmacy-based services report syringe transactions on a quarterly basis to the office of 
the HSE Pharmacy Needle Exchange Programme. The data for static and outreach services were collected on a 
once-off basis for 2012. Some 274,475 syringes were distributed through needle exchange services in 2012 
(Figure 8): 57% through static or outreach sites and 43% through pharmacy-based sites (Figure 9). Dublin Mid-
Leinster distributed the highest number of syringes, mostly through static sites as this is the dominant model in 
this region. Almost all syringes were distributed through pharmacy-based exchanges in the HSE South and HSE 
West as this is the dominant model in these two regions.  
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Figure 8: Number of syringes provided through needle exchange services by region and model of service, 2012 
 
 
 
Figure 9: Proportion of syringes provided through needle exchange services by region and model of service, 
2012 
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Paraphernalia distribution 
 
Most static and outreach needle exchange services were able to provide detailed data on the quantities of 
injecting equipment distributed but two were only able to provide partial information. Combined, 156,575 
syringes were distributed (Table 4):  
 
 Fixed needle and syringe (49%) 
 2ml syringe (35%) 
 1ml syringe (11%) 
 
 
Some 135,696 needles were also distributed. The most prevalent were needles fixed to the syringe (56%), and 
blue needles (34%). Blue needles are used by those who inject into their groin (Table 4).  Additionally, 2,400 
green needles were distributed, which could suggest steroid user attendance at needle exchange, as this is used 
by this particular group to inject.  
 
Some 67,768 vials of water for injection were distributed, which comprised three quantities: 2ml (2%), 5ml 
(13%) and 10ml (85%), (Figure 10). There were 67,928 more needles distributed than vials of water for injection. 
There were 25,450 spoons distributed, indicating that 110,246 more needles than spoons were distributed. The 
discrepancy between needles and other injecting equipment could indicate that some equipment is being used 
more than once. This is not best practice: each piece of equipment should be used only once and then disposed 
of. Other equipment included foil - provided to encourage smoking, rather than injecting drug use - in 13 static 
and outreach services.     
 
A further two services provided 404 crack pipe kits and tourniquets to their service users. 
 
Table 4: Quantities and proportions of needles and syringes distributed, 2012  
 
 Syringes Per cent 
1ml syringe with needle 76206 48.7 
2ml syringe 54875 35 
1ml syringe 25494 16.3 
Total 156,575 100 
 Needles Per cent 
1ml syringe with needle (peripheral 
vein) 
76206  56.2 
Needle blue 30mm (groin vein) 25878  19.1 
Needle: blue  25mm (groin vein) 20056  14.7 
Needle orange (25G peripheral vein) 8648  6.4 
Needle brown (28G peripheral vein) 2513  1.9 
Needle green 40mm (commonly used 
to administer steroids) 
2395  1.7 
Total 135,696 100 
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Figure 10:  Numbers of needles distributed at static and outreach sites, 2012 
 
Pharmacy-based needle exchanges 
 
Pharmacy-based needle exchanges distribute packs containing the equipment required to administer 10 sterile 
injections. The pack contains 10 filter syringes (including needles), 10 stericups, 10 swabs, 10 citric acid packs,  
10 vials with 5ml water for injection and one information leaflet (which contains harm reduction and safer 
injecting advice).  
 
During the period, pharmacy needle exchange services dispensed 117,900 of each of the following: filter 
syringes, stericups, swabs, citric acid and vials of water for injection.  
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Needle Exchange  impact on the spread of BBVs 
 
Although all services said they provided information on BBVs, only two static or outreach needle exchange 
services provided a record of the number of referrals for BBV testing and Hepatitis B vaccination. Five static and 
outreach services reported that a doctor or nurse would have referred patients but such interventions were not 
recorded. The remaining static or outreach services indicated that they did not know the numbers or they left 
the relevant data field blank. Eleven static or outreach services recorded referrals to treatment services and a 
further three reported referrals of service users to other treatment services but did not have a record of the 
number of such referrals.  
 
Referrals from pharmacy-based needle exchange services are recorded systematically and reported to the HSE 
each quarter. This reflects the important role they play in linking affected individuals with preventative, 
diagnostic and treatment services. The numbers presented in Figure 11 are an underestimate of the referral 
activities provided by static and outreach needle exchange services as not all referrals were recorded. Referral 
rates collated as part of the Pharmacy Needle Exchange Programme are more complete as participating 
pharmacies record referrals as part of the data which is returned to the PNEX office.  
 
 
 
Figure 11: Numbers of referrals recorded by model of needle exchange, 2012 
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Contribution of needle exchange to the decrease in the number of HIV and Hepatitis C diagnoses 
HIV surveillance, 1986-2012 
 
Voluntary linked testing for antibodies to HIV has been available in Ireland since 1982. Figure 12 presents the 
number of new cases of HIV among injecting drug users (IDUs) reported in Ireland by year of diagnosis. Data 
from 1982 to 1985 are excluded as these four years were combined in the source records. According to the most 
recent report of the Health Protection Surveillance Committee (HPSC), at the end of 2012, 341 people were 
newly diagnosed with HIV in Ireland (crude notification rate of 7.4 per 100,000 per population) and the figure 
has been declining since 2004.  
 
 
In 2012, 13 (3.8%) newly diagnosed HIV cases were IDUs. The number of diagnoses among IDUs has been 
steadily decreasing - from 71 in 2004 to 13 in 2012 (a decline of 82%). Of the 13 newly diagnosed cases who 
were IDUs, 10 were men and the median age was 34 years (age range 22-to-50 years). Five cases were born in 
Ireland, three in Central and Eastern Europe and two in Western Europe. Among the IDUs newly diagnosed with 
HIV infection, 69% were co‐infected with Hepatitis C (Donnell, et al. 2013). 
 
 
Figure 12 Number and rolling average number of new cases of HIV among IDUs by year of diagnosis reported in Ireland, 1986–2012  
Source: Unpublished data reported to Department of Health by National Disease Surveillance Centre and HPSC, 2013  
 
 
 
 
Hepatitis C notifications, 2012 
 
There were 1,036 Hepatitis C notifications in 2012 (Table 5), a 17.5% decrease on the 1,257 reported in 2011. 
Previous annual numbers have included cases diagnosed in the past, which were not previously notified. 
Decreasing Hepatitis C notifications and increasing median age are indicative of a decline in Hepatitis C. 
Demographic data in 2012 were similar to previous years, with males representing 66% of the 689 cases; the 
median age at notification being 37 years; and 67% of cases being aged between 25 and 44 years.   
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Table 5: Hepatitis C cases and notification rates per 100,000 population, 2004–2012 
   
Year n Notification rate 
2004 1119 26.4 
2005 1403 33.1 
2006 1210 28.6 
2007 1541 36.5 
2008 1511 35.8 
2009 1240 29.3 
2010 1236 29.2 
2011 1257 29.6 
2012 1036 24.4 
Source: Unpublished data from HPSC, 2013  
 
Risk factor data were available for 637 (61%) of the 2012 cases. Of these, 484 (76%) were predominantly at risk 
from injecting. Among this subset, 348 (72%) were men with an average age of 37 years. In the 484 cases where 
injecting was the predominant risk factor, 399 (82%) lived in Dublin and the adjoining counties of Kildare and 
Wicklow. 
 
What other activities do needle exchange services provide? 
 
All of the services reported providing their service users with face-to-face advice on harm reduction and 
overdose as well as referrals to other treatment options and counselling services. 
 
A list of possible interventions was provided in the questionnaire to determine the types of interventions that 
could be offered to the service user.  
 
All of the services reported that they provide at least five or more of the ten interventions listed below: 
 
1. Specific harm reduction advice 
2. Overdose awareness 
3. Basic harm reduction messages repeated at each attendance 
4. Service user referrals to A&E or a GP 
5. Service user referrals to other health, outreach and social care services 
6. Wound care advice 
7. Injection site inspection 
8. Service user referrals for BBV testing and Hepatitis B vaccination 
9. Service user assistance with the referral process e.g. making phone calls 
10. Other health advice 
 
25 
ISBN 978-1-906218-95-9 
 
 
Returns Policy 
 
All needle exchange services were asked about their policies on the return of equipment. All services stated that 
while they encouraged the return of used needles and syringes it was not a condition for accessing new 
equipment.   
 
The review requested data on needle exchange returns.  The collection of this data from static and outreach 
needle exchange services varied. For example, one service averaged the contents of the returned sharps 
containers; two regions reported data on the number of sharps containers and needles returned while some 
services were unable to provide any estimate of returns. The numbers of containers returned are routinely 
reported by pharmacy-based services and are recorded.  
 
Quality Assurance  
 
The questionnaire asked static and outreach needle exchange services to describe the quality assurance and 
clinical governance processes and procedures for needle exchange services.  The governance for pharmacies is a 
statutory requirement under the Pharmacy Act 2007 which gives the Pharmaceutical Society of Ireland powers 
of inspection, investigation and enforcement.  
 
All static and outreach needle exchange services except one said they had a clinical governance policy in place. 
The statutory services said this fell under the aegis of their regional HSE Addiction services.  
 
Three voluntary-based services reported that SafetyNet (a Primary Care Network for Homeless Health Services) 
provided their clinical governance.  
 
One voluntary service reported that the nurse employed in the service provided its clinical governance.   
 
Two voluntary services reported the receipt of in-house clinical governance, stating that:  
 
‘The service is responsible for the quality and satisfaction of service users in the care we deliver’   
Service 1 
 
 ‘The board of directors are responsible for clinical governance or they can appoint a person’ 
Service 2  
 
It would appear all static and outreach needle exchange services work within the NDRIC framework, which is 
designed to ensure service providers offer individuals affected by drug misuse a range of integrated options 
tailored to meet their needs and create for them an individual rehabilitation pathway. 
 
The service provision for children (under 18 years) was reported by two service providers, one statutory HSE 
DML and one voluntary (ALDP) who were providing services within the former  DML Region.   
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These services had in place policies for the provision of needle exchange which complied with QuADS and a 
referral pathway to treatment as these individuals are prioritised for access to services. 
 
Static and outreach needle exchange services were asked how often staff received up-skilling as part of their 
continuous professional development. The replies varied greatly. Most of the services indicated they received 
ongoing training but one statutory service highlighted that its training was: 
 
‘Irregular and ad hoc.  It was dependent on: (A) staff motivation to apply for courses. (B) Whether they 
are allowed to attend training course. (C) Whether there is any training available. There is no ongoing 
training whatsoever. There is generally none [competency assessment] specific to our services which 
have only had a competency assessment once in over 13 years.’ 
 
The Pharmacy Act 2007 introduced mandatory continuing professional development for pharmacists. They are 
therefore required to fulfil the statutory requirement for continuous professional development on an annual 
basis. 
 
Emerging trends 
 
Services reported a variety of emerging drug trends: 
 
● Crystal meth 
● Crack cocaine 
● Ketamine 
● Steroids 
● Tanning products 
● Problematic cannabis smokers 
● Other new synthetic drugs 
 
 
Services reported the following harmful practices: 
 
● Steroid users reusing equipment 
● Poor injecting practices amongst sporadic spontaneous users 
● Homemade crack pipes 
● Cannabis use and debt among the younger population 
● Increase in alcohol use 
● Increase in benzodiazepine and related medication, especially among young women 
● Increase drug use among the Traveller community 
● Greater array of tablets on offer through the internet and on the street 
● Use of tanning products 
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Conclusions 
 
There is little or no doubt that the numbers of newly diagnosed cases of HIV and Hepatitis C in injecting drug 
users have been reduced through a combination of interventions, one of which is needle exchange.  
 
However, information on the provision of needle exchange services seemed to be limited to an up-to-date list of 
needle exchange services. Information tended to be regional and there was no national list of non-pharmacy 
based needle exchange services. 
Data requirements  
 
It is clear that, in contrast to pharmacy-based needle exchange services; there was no standardised approach to 
collecting data on static or outreach needle exchange services. In addition, specific services reported difficulties 
with the continued use of paper-based systems, with inputting data onto the Drug Addiction Information System 
(DAIS) and a lack of availability of computers.  
 
Data collection is very important to ensure that the information on the numbers attending and the processes 
followed by each service are recorded to demonstrate service output and to provide evidence that objectives 
are being achieved. Static and outreach services should be facilitated to provide a minimum dataset to ensure 
that national and European standards are met. In addition, a consensus on the recording of returns is required. 
 
 
Hepatitis C strategy 
 
It is evident pharmacies are using the referral pathways to their local services and providing a point of contact to 
assist in informing service users of prevention, testing and treatment options. Ad hoc reports indicate that static 
and outreach needle exchange services do refer people to drug treatment, BBV testing services and other health 
and social services. However, hard data to confirm this is essential.  
 
The National Hepatitis C Strategy 2009-2014 states that needle exchange services need to: 
 
‘Offer and promote screening for Hepatitis C and other blood-borne diseases to those who attend 
services such as needle exchange programmes and other harm reduction services.’ 
 
At present, needle exchange sites are not trained or resourced to provide such services and training and up 
skilling should be considered. 
Reducing or preventing injecting 
 
Currently in the Netherlands, foil is available in all needle and syringe exchange programmes and consumption 
rooms which has led to a reduction in the incidence of HIV and overdoses, (Kools, 2009).  
 
Over the past decade ‘HIV prevalence had fallen from 8.5 per cent to virtually zero in Amsterdam, and the 
number of fatal overdoses had also drastically decreased’  (Kools, 2010). The distribution of foil could be 
considered a useful intervention to prevent the move from smoking to injecting and reduce the incidence of 
injection among smokers. 
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Ensuring single use only 
 
According to WHO, best infection control practices for intradermal, subcutaneous and intramuscular injections 
recommend the use of a new, single use injection device for each injection and, in addition, the equipment 
required to prepare heroin and other drugs, such as spoons, filters and water,  (Hutin et al, 2003). 
 
Procurement approaches 
 
The quantities and prices of equipment, staffing, building and other related costs were not provided in this 
report. Such data should be made available to determine whether expenditure is in line with budgets and if 
economies of scale might be achieved through a tender process.  
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Key Recommendations  
 
Service user feedback 
 
A service user satisfaction survey of all the different NEX services should be carried out in line with Goal 6 of 
the HSE National Strategy for Service User Involvement in the Irish Health Service 2008-2013.  
 
Data collection 
 
A standardised electronic reporting mechanism for regular monitoring and reporting of all needle exchange 
transactions should be considered; preferably as part of the HSE Primary Care ICT system. NEX service 
information should ideally be reported to a central office on a quarterly basis. 
 
Unique identifier 
 
A unique identifier for each service user should be developed to remove the risk of an individual being 
counted more than once in a reporting year. The unique identifiers need to comply with the obligations of 
the Data Protection Act 1988, the Data Protection (Amendment) Act 2003 and SI535 of 2003 (as amended). 
The HSE has proposed to use a health service identification number for the each individual in the state for 
use in health or social care services and if possible the unique identifier should be linked to a health 
identifier, while preserving the anonymous nature of the service. 
 
Image and Performance Enhancing Drugs (IPEDs) 
 
Needle Exchange  services should collect data from those who are using image performance and enhancing 
type drugs as this has been highlighted as an emerging trend. 
 
 
 
NEX Service Training and Policies 
 
All NEX service providers should  ensure  training complies with recognised standards, such as the Quality in 
Alcohol and Drug Services (QuADS, UK) Organisational Standards; the Hepatitis C Strategy 2011, 
Recommendation 20; and Building a Culture of Patient Safety 2008- Report of the Commission on Patient 
Safety and Quality Assurance. 
 
NEX service providers must ensure policies and procedures are in place to comply with QuADs, (UK) 
Organisational Standards. 
 
NEX service providers must also operate an effective clinical governance framework in line with QuADS, (UK) 
Organisational Standards or an equivalent professional body. 
 
 
 
Blood Borne Virus (BBV) testing and Hepatitis B vaccination 
 
NEX service providers should examine potential barriers to BBV testing and immunisation in order to 
improve testing and immunisation uptake. 
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Equipment and supply considerations 
 
Equipment supplied should be of high quality and meet European safety standards where available. 
Consideration should be given to including stericups, filters and foil in every NEX service (this is not currently 
the case). 
Stock provision for all non-pharmacy NEX services should be centrally purchased and distributed to ensure 
value for money, quality and consistency of equipment. 
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Submissions  
 
 One submission has been made regarding the expansion of the pharmacy needle exchange programme:  
 
Better City for All Implementation Group 
 
Following a presentation made to the group by Tim Bingham and Denis O’ Driscoll, the Better City for All report 
(2012) recommended an extension of the pharmacy needle exchange programme across Dublin City and County. 
This document highlights the trend whereby a significant amount of individuals are using services in Dublin City 
from regions outside of the capital, which is putting additional pressure on resources. Since these 
recommendations were published, the data suggests a reduction in the number of individuals using services in 
the Dublin Region because as they are accessing them locally instead. 
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Appendix 1 
 
Name of service provider__________________________ 
Type of service, (please fill out separate forms if more than one type of service provided by your organisation) 
 
Static   
Backpacking ( Only)  
Van (Only)  
 
1. Coverage  of the service provided 
● Details of towns covered by mobile outreach services 
● Static Address of service(s) 
 
 
 
 
 
 
 
 
2 .How many hours a week is the Needle Exchange  service open  
 Day Time 
9am – 6pm 
Evenings 6pm 
onwards 
Weekends Total Hours 
Static     
Outreach     
Mobile     
 
3. Number of staff who are trained - provide needle exchange service 
 
 
4. Please provide details of the level of service delivery and peripatetic service  
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5. How many Needle Exchange  transactions were reported 2012? 
 Male Female Unknown Total 
2012     
 
6. How many unique individuals made contact with the service in 2012? 
 Male Female Unknown Total 
2012     
 
7. Amount of equipment which was distributed in  2012 to each service user – per transaction 
Key B = Blue, G= Green,  O = Orange, 1ml fixed = 1ml diabetic / orange top , BR =Brown 
 Barrel  Needle Water 
for 
Injection 
        
 1ml 
fixed 
1ml  2ml 5ml B 
25mm 
B 
30mm 
G 
40mm 
BR 26G  O 25mm 2ml 5ml 10ml 
Static 
 
            
Outreach 
 
            
Mobile 
van 
 
            
Total  
 
           
 
 
 
One 
hit kit 
packs 
Sharps 
Bins 
Condoms Foil 
packs 
Wipes  
swabs 
Citric acid/Vit 
C  
Tourniquets Filters 
Static         
Outreach         
Mobile          
 
8. Please give details of the supplier of the stock for the needle exchange service  
 
 
 
 
9. If an emergency pack has been supplied, what were the contents of the pack ? 
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10. Other equipment supplied please give details 
 
 
 
 
 
 
 
 
11. Does your service provide Crack Pipes  Yes / No 
If yes  please provide details of the kits and name of manufacturer  
 
 
 
 
12. Number of crackpipe Kits distributed in 2012  
Male  Female 
  
Total   
 
13 . Return rate of sharps containers in 2012 
Male Female Unknown Total 
    
 
14. Policy on return of used needles /syringes  
Service operates a strict one individual needle 
/ syringe  for one exchange policy 
 
 
Service always requires some return of used 
needles / syringes before new equipment is 
provided 
 
Service encourages return of used needles 
and syringes but this is not a condition for 
accessing new equipment 
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15. How is data recorded, (e.g. if a computer system is used which computer system) and who is it reported to 
? 
 
 
 
 
 
 
 
 
16. What is the organisation’s peer /secondary exchange policy ? 
 
 
 
 
 
 
 
 
 
17. How many referrals for Blood Bourne Virus Testing in 2012 were made? 
 Male Female Unknown Total 
Hep B Testing     
Hep C Testing     
HIV testing     
Other     
 
18. In how many of these referrals was it possible to track from referral through to treatment 
assessment? 
 Male Female Unknown Total 
Hep B      
Hep C      
HIV      
Other     
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19. How many people were referred on to tier 3 and tier 4 services in 2012 ? 
 Male Female Unknown Total 
Methadone 
programme 
    
Counselling  
 
   
Stabilisation  
 
   
Residential 
treatment 
    
Detox service  
 
   
Other     
 
20. How many service users were given 
 Male Female Not quantified Total  
Overdose 
awareness 
training 
    
Safer injecting 
advice 
 
 
   
 
21. Does the organisation work within the framework of NDRIC care planning and referral pathways   
Yes /No  
 
22. Briefly summarise the  organisation understand  about the NDRIC care planning and referral pathways 
work  
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Clinical Governance  
23. Does the organisation have a Under 18’s policy Yes/No 
If  yes , outline what is it? And who or which organisation  provides the governance (oversight) ?  
 
 
 
 
24. Does the organisation have appropriate insurance to undertake Needle Exchange service: 
A. Within the buildings you operate? Yes/No 
B. Backpacking? Yes /No 
C. Mobile units? Yes / No 
 
25. Does the organisation have clinical governance for needle exchange and who / what organisation provides 
such governance? 
 
 
 
 
 
 
 
26 . What does the organisation understand by the term clinical governance ? 
 
 
 
 
 
 
 
27. What policies does the organisation have in relation to the provision of needle exchange? 
Please provide the evidence 
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28. How often does the organisation undertake an audit and what is their job title?  
 
 
 
 
 
29. How often do staff receive up skilling and competency assessments? 
 
 
 
 
 
30. Has the service seen any new drugs (i.e. steroid use, tanning, new psychoactive substances)  or new 
emerging harmful practices ? 
New Drugs 
 
 
 
 
 
 
Emerging harmful practices 
 
 
 
 
 
 
 
Please supply the template used for recording needle exchange transaction  
Name and contact details of person completing the effectiveness review 
 
____________________________________________________________ 
 
Date _________________ 
 
 
 
 
